---
title: "Ivenix Infusion System (IIS), LVP Software; LVP-SW-0004 version 5.2.0 — FDA record Z-0002-2023 | Is It on Recall"
description: "The display screen may become frozen and unresponsive to user input, triggering an alarm that is evidenced by a buzzer sound and flashing red LEDs as a secondar"
url: https://isitonrecall.com/recall/fda-device-z-0002-2023-ivenix-infusion-system-iis-lvp-software-lvp-sw-0004-version-5-2-0/
updated: 2026-10-01
site: "Is It on Recall"
language: en
---

[Recall archive](https://isitonrecall.com/archives/) / FDA device enforcement

# Ivenix Infusion System (IIS), LVP Software; LVP-SW-0004 version 5.2.0 — FDA record Z-0002-2023

Reported terminated

Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.

Source date Sep 8, 2022. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; [check FSIS directly](https://www.fsis.usda.gov/recalls). [Source coverage and dates](https://isitonrecall.com/sources/).

## What the record says

- **Product**: Ivenix Infusion System (IIS), LVP Software; LVP-SW-0004 version 5.2.0
- **Reason**: The display screen may become frozen and unresponsive to user input, triggering an alarm that is evidenced by a buzzer sound and flashing red LEDs as a secondary notification. However, as the screen goes blank it does not indicate an alarm condition or respond. This issue leads to temporary cessation of flow of a medication or fluid, requiring immediate intervention by the clinician.
- **Classification**: Class I
- **Recalling firm**: Fresenius Kabi USA, LLC
- **Quantity**: 4 instances
- **Agency-reported status**: Terminated
- **Source record identifier**: Z-0002-2023

[Open the official record](https://api.fda.gov/device/enforcement.json?search=recall_number%3A%22Z-0002-2023%22)

[What the recall classes mean](https://isitonrecall.com/guides/recall-classes/). Classification is an agency assessment, not individual medical advice.

## Lot and product identifiers

| Label field | Details supplied by the agency |
| --- | --- |
| Lot, code or applicability | UDI-DI: 00811505030122 version 5.2.0 |

Match all identifying details in the current notice. A brand name alone is not enough.

## Distribution

Domestic distribution to NJ and WI.

States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.

- [New Jersey](https://isitonrecall.com/state/new-jersey/)
- [Wisconsin](https://isitonrecall.com/state/wisconsin/)

## Dates in the source

- **Report date**: Oct 12, 2022
- **Recall initiation date**: Sep 8, 2022
- **Center classification date**: Oct 6, 2022
- **Termination date**: Sep 10, 2024

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.

## What to do next

Read the official notice for the action that applies to your exact product.

[Read the current instructions](https://api.fda.gov/device/enforcement.json?search=recall_number%3A%22Z-0002-2023%22)

## Related records

[Medical devices records](https://isitonrecall.com/category/medical-devices/) [Fresenius Kabi USA, LLC records](https://isitonrecall.com/brand/fresenius-kabi-usa-llc/)